Author: Alex Drijver



May 20, 2014 - Presentation
ChemAxon’s user group meeting (UGM) in 2014, Budapest started with a keynote, a talk between our CEO, Alex Drijver and Ian Berry, Manager, Informatics at Evotec, a contract research…

The challenges facing the modern large pharma R&D manager, an exchange of views

May 17, 2011 - Presentation
Pistoia, pharmageddon, changing technology landscapes, Diseases of the Developing World and business as usual. Today’s R&D IT managers face multiple challenges. Ashley George t…

Keynote: Future-proofing - managing systems in rapidly changing times

Sep 25, 2012 - Presentation
Our CEO, Alex Drijver and Ramesh Durvasula, Director for Molecular Sciences, Candidate Optimization & Drug Safety at Bristol-Myers Squibb, are discussing the future of the industry, …


May 28, 2013 - Presentation
The keynote speech of the European User Group Meeting is actually a rather informal talk. In 2013 our CEO, Alex Drijver and Oliver Wissdorf, Boehringer Ingelheim will discuss the largest …

Keynote to the 2012 European User Group Meeting

May 22, 2012 - Presentation
The keynote speech of the European User Group Meeting is actually a rather informal talk between our CEO, Alex Drijver and Kent Stewart, Abbott. The speakers in this opening presentation …

CEO closing

May 18, 2011 - Presentation
ChemAxon’s philosophy is to develop and enhance products in partnership with customers—to respond to their needs and so to continually improve the product line. It prides itself o…


Sep 25, 2014 - Presentation
The keynote talk of our Cambridge User Group Meeting was presented by our CEO, Alex Drijver.

Closing words

May 29, 2013 - Presentation
A quick summary of the User Group Meeting by the Chief Executive Officer of the company.

Closing remarks

Sep 26, 2012 - Presentation
The closing words and some conclusions of the 2012 USUGM of ChemAxon, presented by our CEO, Alex Drijver.

Supporting Open Innovation with Novel Software Solutions

Nov 14, 2012 - Poster
As pharma companies find themselves in an increasingly tight corner regarding pharmageddon less and less money is available for primary research. This has led to the rapid rise of Open In…

Welcome and CEO's introduction

Sep 14, 2010 - Presentation
We use open partnering to describe the way we communicate with all our partners – where open equals our transparency in business and development modeling and partnering means our cl…

Closing remarks

Sep 15, 2010 - Presentation
Following the terms of thanks to the presenters of the User Group Meeting, to the attendees and to the organizers, the most important message of the CEO’s closing talk is that ChemA…

Closing Remarks

Sep 25, 2013 - Presentation
ChemAxon’s CEO wraps up with his thoughts of the meeting

Welcome and CEO Keynote

Sep 15, 2009 - Presentation
Brief overview of the ChemAxon focusing to recent changes in development, new features at the company and other related news in the industry.


Sep 24, 2013 - Presentation
Extracted from Wendy Warr’s Meeting Report: Continuing a recent tradition, the UGM proper began not with a keynote address but with Alex Drijver, CEO of ChemAxon interviewing Mar…

Out of the frying pan and into the fire

Jun 3, 2009 - Presentation
First there were internal industry woes and reorganization, and then there come financial turmoil. ChemAxon perspectives on staying ahead in tumultuous times.
enjoy, share

Company Introduction

Aug 7, 2008 - Presentation
Future strategy, current developments, long term plans, mission & vision.

Keynote: Surviving the whitewater of R&D Informatics: How can we best support science in an everchanging world

Sep 27, 2011 - Presentation
Combining trends in business strategy and informatics to drive a stable and strategic informatics portfolio